Researchers evaluated data of more than 200 patients to see whether a thrombopoietin receptor agonist could serve as an alternative to blood transfusion in thrombocytopenia and chronic liver disease.
Researchers examined 5-year follow-up data on patients enrolled in the Appendicitis Acuta study, which compared appendectomy and antibiotic therapy for the treatment of acute appendicitis.
In a recent study, researchers sought to determine how inflammatory bowel disease affects the risk of influenza infection, and whether treatment with various IBD medications affected this risk.
There are currently no FDA-approved therapeutics for treating NAFLD, but many options are on the horizon. Steven Grinspoon, MD, discussed the options in this session.
